Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Mar 21;17(3):e0264232. doi: 10.1371/journal.pone.0264232

Professional practice for COVID-19 risk reduction among health care workers: A cross-sectional study with matched case-control comparison

Sarah Wilson 1,#, Audrey Mouet 1, Camille Jeanne-Leroyer 1, France Borgey 2, Emmanuelle Odinet-Raulin 3, Xavier Humbert 4, Simon Le Hello 1,5,#, Pascal Thibon 2,*,#
Editor: Ginny Moore6
PMCID: PMC8936447  PMID: 35313328

Abstract

Background

Health care workers (HCWs) are particularly exposed to COVID-19 and therefore it is important to study preventive measures in this population.

Aim

To investigate socio-demographic factors and professional practice associated with the risk of COVID-19 among HCWs in health establishments in Normandy, France.

Methods

A cross-sectional and 3 case-control studies using bootstrap methods were conducted in order to explore the possible risk factors that lead to SARS-CoV2 transmission within HCWs. Case-control studies focused on risk factors associated with (a) care of COVID-19 patients, (b) care of non COVID-19 patients and (c) contacts between colleagues.

Participants

2,058 respondents, respectively 1,363 (66.2%) and 695 (33.8%) in medical and medico-social establishments, including HCW with and without contact with patients.

Results

301 participants (14.6%) reported having been infected by SARS-CoV2. When caring for COVID-19 patients, HCWs who declared wearing respirators, either for all patient care (ORa 0.39; 95% CI: 0.29–0.51) or only when exposed to aerosol-generating procedures (ORa 0.56; 95% CI: 0.43–0.70), had a lower risk of infection compared with HCWs who declared wearing mainly surgical masks. During care of non COVID-19 patients, wearing mainly a respirator was associated with a higher risk of infection (ORa 1.84; 95% CI: 1.06–3.37). An increased risk was also found for HCWs who changed uniform in workplace changing rooms (ORa 1.93; 95% CI: 1.63–2.29).

Conclusion

Correct use of PPE adapted to the situation and risk level is essential in protecting HCWs against infection.

Introduction

Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization on March 11th 2020. There have since been approximately 216,000,000 cases and over 4,500,000 deaths worldwide [1]. Healthcare personnel are particularly vulnerable to infection given their exposure to the virus [2]. Between March 2020 and May 2021, 85,137 HCWs have been declared infected by the SARS-CoV2 virus in France, of which there have been 19 deaths. Within the infected personnel, 69% worked in clinical areas. The professions with the highest amount of infections were nurses (24% of cases) and nursing assistants (21%) [3].

SARS-CoV2 can be spread by respiratory droplets and fomite contact, as well as airborne transmission in specific circumstances [4,5]. However most transmissions occur during close face-to-face contact via respiratory droplets. The virus can be transmitted by presymptomatic, asymptomatic and symptomatic carriers [6,7]. Protection of HCWs is a key method for controlling the spread of the virus within health establishments, as vaccination does not provide complete protection against onward transmission. [8]. Guidelines recommend that when in contact with COVID-19 patients, and in addition to hand hygiene, HCWs protect themselves with personal protective equipment (PPE), namely surgical masks for standard care and respirators during aerosol-generating procedures, gowns and protective goggles [9,10]. Studies have suggested that SARS-CoV2 spreads not only between patients and from patients to HCWs, but also between infected HCWs, for example during breaks [7,11,12].

This study investigated sociodemographic factors, behavioral factors and professional practice associated with the risk of COVID-19 infection in healthcare workers. Secondary aims were to describe the circumstances of infection declared by the respondents, and the protective measures applied by healthcare professionals working in clinical areas, as well as during contacts with other colleagues.

Methods

Study design

A cross-sectional and three case-control matched studies were performed, based on an anonymous online questionnaire.

Participants

Healthcare personnel (medical and paramedical professionals, as well as personnel from laboratories, hospital pharmacies and administration) working in health establishments (hospitals, clinics, rehabilitation and recuperation care facilities and establishments specializing in psychiatry), nursing homes and establishments for handicapped children and adults in Normandy, France, were invited to participate in the study.

Location

The study was conducted in Normandy, a region located in Northwestern France comprising of 6 departments (Calvados, Eure, Manche, Orne, Seine-Maritime), populated by 3,300,000 inhabitants [13], and with around 90,000 HCWs working in 197 health establishments, 522 establishments for handicapped adults and children, and 348 nursing homes [14].

Rights and ethics

The study was approved by the local ethics committee for health research of Caen university hospital (ID 2293) on March 24th 2021. Participants received detailed information on the objectives of the study. Written agreement to use the anonymous data collected via the questionnaire was obtained for all participants, and they were informed of the possibility of the withdrawal of their data at any time, according to European regulation (27th April 2016).

Period and data acquisition

The online questionnaire was available from 29th March 2021 to 30th June 2021. Healthcare personnel working in hospitals were invited to participate in the study by hospital management, who relayed the online version of the questionnaire. Healthcare workers from the medico-social sector were contacted by their management following an invitation to participate in the study via an email from the Regional Health Agency. The online questionnaire covered socio-demographic characteristics of HCWs (age, sex and profession), workplace, history of COVID-19 infection with date of infection (confirmed by a positive SARS-CoV2 PCR or antigenic test) as well as suspected exposures leading to COVID-19 infection, COVID-19 vaccination status, and personal preventative equipment and other barrier measures applied at work. For respondents who reported having been infected by SARS-CoV2, the personal preventative equipment and barrier measures were those applied at work during the ten days preceding infection symptoms (or testing in case of asymptomatic infection). For respondents with no history of COVID-19 infection, these measures were those applied at the time of filling in the questionnaire, and participants were asked if these practices had changed since September 2020.

Cases and controls definition

Three case-control analyses were led, the first one describing measures applied during the care of COVID-19 patients, the second one those applied during the care of non-COVID-19 patients and the third one describing contacts with colleagues. Cases were defined as healthcare personnel who declared having had a COVID-19 infection (confirmed by a positive SARS-CoV2 PCR or antigenic test) which they reported as having been acquired in the workplace. Controls were healthcare personnel who declared no known history of COVID-19 infection over the study period and who declared no modifications of the personal preventative measures they applied since September 2020. Cases and controls were matched by sector of activity (health establishment or medico-social establishment) and by profession, with 4 controls for 1 case.

The study period for the case-control studies was defined as the period between the 1st September 2020 and the 31st January 2021, corresponding to the second wave of the COVID-19 pandemic in France, when recommendations for barrier measures had been issued [10], and PPE was widely available. The cut-off point was chosen in order to study the effects of sociodemographic factors, behavioral factors and professional practice before wide-spread vaccination of HCWs that started in January 2021.

Statistical analysis

Qualitative variables were described with their effectives and percentages, and compared using the Chi-squared test. For each case-control study, the association between exposures and COVID-19 infection was measured by computing odds-ratios (OR) with univariate conditional logistic regression analysis, to take into account the matching of cases and controls on sector of activity and profession. As selecting a single set of controls could have led to an incorrect measurement of association due to random variations of ORs, we used a bootstrap method to perform 1,000 random samplings of controls, with replacement. We then computed the mean ORs and their 95% confidence intervals (CI) (i.e. the 2.5% and 97.5% quantiles of the distribution of the 1,000 ORs) for each exposure. All variables significantly associated with risk of infection in the initial analysis were included in the multivariable analysis after testing for absence of collinearity between variables. Analyses were performed using multivariate conditional logistic regression analysis and the same bootstrap method, allowing to calculate adjusted ORs (ORa).

P < .05 was considered significant. The analyses were performed in R version 4.1.1 (R Development Core Team).

Results

The cross sectional study included 2,058 complete responses filled in by HCWs. The majority of participants worked in medical establishments (1,363, 66.2%) and 695 (33.8%) worked in medico-social establishments. A large proportion of participants (791, 38.0%) worked in non-medical areas, regardless of the type of establishment. Nurses and nursing assistants represented 31.3% of respondents (N = 645), and doctors 10.3% (N = 212). The percentages of nurses, nursing assistants and doctors were higher within respondents in health establishments than in medico-social establishments (p<10−3). Most of the participants were women (N = 1,680, 81.6%), and their age was predominantly between 30 and 49 (N = 1,215, 59.0% of respondents) (Table 1). Within health establishments, most of the HCWs worked in general hospitals or University Hospital Centers (N = 1,233, 90.5%), 5.0% (N = 68) worked in psychiatry and 2.0% (N = 27) in rehabilitation and recuperation care facilities. Nursing homes represented the workplace for a large part of HCWs in medico-social establishments (N = 267, 38.4%).

Table 1. Participants’ characteristics, globally, and by sector of activity.

Characteristics Health establishments N (%) Medico-social establishments N (%) Total N (%)
Professions
    Nurses 334 (24.5) 55 (7.9) 389 (18.9)
    Nursing assistants 182 (13.4) 74 (10.7) 256 (12.4)
    Doctors 187 (13.7) 25 (3.6) 212 (10.3)
    Other HCWs in contact with patients 198 (14.5) 222 (31.9) 420 (20.4)
    Other HCWs not in contact with patients 462 (33.9) 319 (45.9) 781 (38.0)
Age (years)
    <30 198 (14.5) 97 (14.0) 295 (14.3)
    30–39 389 (28.5) 184 (26.5) 573 (27.8)
    40–49 416 (30.5) 226 (32.5) 642 (31.2)
    > = 50 360 (26.4) 188 (27.1) 548 (26.6)
Sex
    Female 1,110 (81.4) 570 (82.0) 1,680 (81.6)
    Male 253 (18.6) 125 (18.0) 378 (18.4)
Vaccination status
    Vaccinated, 1 dose 481 (35.3) 194 (27.9) 675 (32.8)
    Vaccinated, 2 doses 549 (40.3) 219 (31.5) 768 (37.3)
    Non-vaccinated 333 (24.4) 282 (40.6) 615 (29.9)
Amongst the non-vaccinated
    Wish to be vaccinated 140 (42.1) 133 (47.2) 273 (44.4)
    Do not wish to be vaccinated 123 (36.9) 103 (36.5) 226 (36.7)
    Do not know if they wish to be vaccinated 70 (21.0) 46 (16.3) 116 (18.9)
History of COVID-19 196 (14.4) 105 (15.1) 301 (14.6)

HCW: Healthcare worker.

At the time of filling in the questionnaire, over two thirds of respondents (N = 1,443, 70.1%) had received at least one dose of the COVID-19 vaccine, and 11.0% (N = 226) did not wish to be vaccinated.

There were 301 participants with history of COVID-19 (14.6%). The percentage of respondents with history of COVID-19 was similar in health establishments and in medico-social establishments, but differed according to the profession (p<10−3): 22.3% (57/256) for nursing assistants, 17.2% (67/389) for nurses, 16.1% (34/212) for doctors, 13.1% (55/420) for other HCWs in contact with patients, and 11.3% (88/781) for HCWs not in contact with patients. Most respondents with history of COVID-19 declared symptoms associated with the infection (N = 261, 86.7%). Ten respondents were hospitalized with COVID-19, and one participant needed treatment in an intensive care unit. The majority of participants who had had COVID-19 reported the possible contamination source as being at their workplace (N = 171, 56.8%), of which 67.8% (N = 116) reported a contamination due to contacts with a COVID-19 positive patient and 32.2% (N = 55) due to contacts with a COVID-19 positive colleague. Approximately a quarter of respondents (N = 75, 24.9%) reported having been contaminated outside of the workplace and 18.3% (N = 55) of respondents didn’t know how they were infected. In 2020, most cases occurred in March, April, September, October, November and December. In 2021, most cases occurred at the beginning of the year (January, February and March).

Table 2 presents the results of the case-control study performed among HCWs caring for COVID-19 patients. When compared with mainly use of surgical masks, the use of respirators during aerosol-generating procedures (ORa 0.56; 95% CI: 0.43–0.70) and the use of respirators for all care (ORa 0.39; 95% CI: 0.29–0.51) were both associated with a decreased risk of infection. Wearing a hair cap (ORa 0.78; 95% CI: 0.63–0.98) was also associated with a decreased risk of infection. Use of face shields or protective goggles, gowns, protective overshoes and use of gloves for all types of patient care, as well as regular airing of patients’ or residents’ rooms were not associated with risk of infection.

Table 2. Case-control study 1: Exposures associated with risk of COVID-19 among HCWs caring for COVID-19 patients.

Characteristics Cases* (n = 70) Controls* (n = 280) OR [95% CI] ORa [95% CI]
Age (years)
    < 30 14 (20.0) 55 (19.6) 1 (ref) 1 (ref)
    30–39 22 (31.4) 84 (28.9) 1.06 [0.87–1.30] 1.16 [0.93–1.44]
     40–49 17 (24.3) 85 (30.4) 0.91 [0.73–1.10] 0.97 [0.76–1.20]
    ≥ 50 17 (24.3) 59 (21.1) 1.34 [1.05–1.67] 1.26 [0.97–1.61]
Sex
    Female 61 (87.1) 239 (85.4) 1 (ref)
    Male 9 (12.9) 41 (14.6) 0.85 [0.66–1.08]
Preventative measures (PPE wearing and other)
Handrubbing with alcohol based handrub before and after patient care
    Never/rarely 0 (0) 8 (2.9) -
    Regularly/always 70 (100) 272 (97.1) -
Type of mask used
    Mainly surgical masks 22 (31.4) 55 (19.6) 1 (ref) 1 (ref)
    Surgical masks + respirators during aerosol-generating procedures 35 (50.0) 148 (52.9) 0.54 [0.43–0.65] 0.56 [0.43–0.70]
    Mainly respirators 13 (18.6) 77 (27.5) 0.38 [0.29–0.46] 0.39 [0.29–0.51]
Face shield or protective goggles
    Never/rarely 30 (42.9) 106 (37.9) 1 (ref) 1 (ref)
    Regularly/always 40 (57.1) 74 (62.1) 0.82 [0.70–0.94] 1.27 [0.99–1.55]
Disposable gown and plastic apron when needed
    Never/rarely 13 (18.6) 37 (13.2) 1 (ref) 1 (ref)
    Regularly/always 57 (81.4) 243 (86.8) 0.64 [0.50–0.79] 0.96 [0.70–1.26]
Gloves, for all types of patient care
    Never/rarely 12 (17.1) 48 (17.1) 1 (ref)
    Regularly/always 58 (82.9) 232 (82.9) 0.99 [0.78–1.22]
Protective hair cap
    Never/rarely 33 (47.1) 106 (37.9) 1 (ref) 1 (ref)
    Regularly/always 37 (52.9) 174 (62.1) 0.67 [0.58–0.78] 0.78 [0.63–0.98]
Protective overshoes
    Never/rarely 56 (80.0) 218 (77.9) 1 (ref)
    Regularly/always 14 (20.0) 62 (22.1) 0.88 [0.74–1.05]
Regular airing of patients/residents’ rooms
    Never/rarely 24 (34.3) 91 (32.5) 1 (ref)
    Regularly/always 46 (65.7) 189 (67.5) 0.91 [0.76–1.07]

OR: Odds ratio. ORa: Adjusted odds ratio.

* Cases and controls were matched on workplace and occupation.

Table 3 describes the results of the case-control study performed among HCWs not caring for COVID-19 patients. Wearing mainly a respirator (ORa 1.84; 95% CI: 1.06–3.37) was found to be associated with a higher risk of infection when compared to mainly use of surgical masks. Use of a face shield or protective goggles (ORa 3.10; 95% CI: 1.81–5.58) and use of gloves for all types of patient care (ORa 1.36; 95% CI: 1.10–1.67) were also associated with a higher risk of infection. No association with infection was found for use of gowns and plastic aprons, protective hair caps and overshoes, and for regular airing of patients/residents’ rooms.

Table 3. Case-control study 2: Exposures associated with risk of COVID-19 among HCWs taking care of non COVID-19 positive patients.

Characteristics Cases* (n = 84) Controls* (n = 336) OR [95% CI] ORa [95% CI]
Age (years)
    < 30 17 (20.2) 66 (19.6) 1 (ref)
    30–39 25 (29.8) 103 (30.7) 0.95 [0.75–1.19]
    40–49 23 (27.4) 103 (30.7) 0.94 [0.73–1.20]
    ≥ 50 19 (22.6) 64 (19.0) 1.05 [0.80–1.36]
Sex
    Women 72 (85.7) 284 (84.5) 1 (ref)
    Men 12 (14.3) 52 (15.5) 0.91 [0.72–1.15]
Preventative measures (PPE wearing and other)
Handrubbing with alcohol based handrub before and after patient care
    Never/rarely 0 (0) 17 (5.1) -
    Regularly/always 84 (100) 319 (94.9) -
Type of mask used
    Mainly surgical masks 60 (71.4) 245 (72.9) 1 (ref) 1 (ref)
    Surgical masks + respirators during aerosol-generating procedures 19 (22.6) 78 (23.2) 1.01 [0.83–1.21] 0.81 [0.66–1.00]
    Mainly respirators 5 (6.0) 13 (3.9) 2.36 [1.45–4.00] 1.84 [1.06–3.37]
Face shield or protective goggles
    Never/rarely 76 (90.5) 327 (97.3) 1 (ref) 1 (ref)
    Regularly/always 8 (9.5) 9 (2.7) 3.78 [2.34–9.97] 3.10 [1.81–5.58]
Disposable gown and plastic apron when needed
    Never/rarely 62 (73.8) 273 (81.2) 1 (ref) 1 (ref)
    Regularly/always 22 (26.2) 63 (18.8) 1.59 [1.29–1.96] 1.22 [0.93–1.57]
Gloves, for all types of patient care
    Never/rarely 34 (40.5) 167 (49.7) 1 (ref) 1 (ref)
    Regularly/always 50 (59.5) 169 (50.3) 1.56 [1.29–1.88] 1.36 [1.10–1.68]
Protective hair cap
    Never/rarely 79 (94.0) 321 (95.5) 1 (ref)
    Regularly/always 5 (6.0) 15 (4.5) 1.33 [0.91–2.06]
Protective overshoes
    Never/rarely 83 (98.8) 331 (98.5) 1 (ref)
    Regularly/always 1 (1.2) 5 (1.5) 0.73 [0.40–1.40]
Regular airing of patients/residents’ rooms
    Never/rarely 28 (33.3) 124 (36.9) 1 (ref)
    Regularly/always 56 (66.7) 212 (63.1) 1.19 [0.99–1.42]

OR: Odds ratio. ORa: Adjusted odds ratio.

* Cases and controls were matched on workplace and occupation.

Table 4 describes the risk of infection associated with contacts between colleagues and airing of communal areas. No association with infection was found for eating at the workplace canteen, taking breaks with other colleagues, and airing of communal areas. Changing of outfit in the workplace changing rooms was associated with a higher risk of infection (ORa 1.93; 95% CI: 1.63–2.29). Participation in professional meetings was associated with a decreased risk (ORa 0.72; 95% CI: 0.60–0.84).

Table 4. Case-control study 3: Contacts between colleagues and airing of communal areas and risk of COVID-19 (all professions included).

Characteristics Cases* (n = 109) Controls* (n = 436) OR [95% CI] ORa [95% CI]
Age (years)
    < 30 19 (17.4) 69 (15.8) 1 (ref)
    30–39 32 (29.4) 128 (29.4) 1.02 [0.85–1.28]
    40–49 31 (28.4) 128 (29.4) 1.03 [0.74–1.26]
    ≥ 50 27 (24.8) 111 (25.4) 1.11 [0.88–1.34]
Sex
    Female 93 (85.3) 364 (83.5) 1 (ref)
    Male 16 (14.7) 72 (16.5) 0.86 [0.70–1.04]
Contacts with colleagues
Eating at the workplace canteen
    Never/rarely 63 (57.8) 252 (57.8) 1 (ref)
    Regularly/always 46 (42.2) 184 (42.2) 1.00 [0.86–1.14]
Breaks with other colleagues
    Never/rarely 44 (40.4) 171 (39.2) 1 (ref)
    Regularly/always 65 (59.6) 265 (60.8) 0.95 [0.82–1.10]
Change of outfit in workplace changing rooms
    Never/rarely 43 (39.4) 225 (51.6) 1 (ref) 1 (ref)
    Regularly/always 66 (60.6) 211 (48.4) 1.92 [1.61–2.30] 1.93 [1.63–2.29]
Participation in professional meetings
    Never/rarely 92 (84.4) 349 (80.0) 1 (ref) 1 (ref)
    Regularly/always 17 (15.6) 87 (20.0) 0.73 [0.60–0.89] 0.72 [0.60–0.84]
Airing of communal areas
    Never/rarely 28 (25.7) 114 (26.1) 1 (ref)
    Regularly/always 81 (74.3) 322 (73.9) 1.03 [0.96–1.21]

OR: Odds ratio. ORa: Adjusted odds.

* Cases and controls were matched on workplace and occupation.

Discussion

This study covered a wide range of health establishments and professions and focused on a period during which PPE was available and before widespread vaccination of HCWs in France. We found that when caring for COVID-19 patients, HCWs who declared using respirators, either for all patient care or only when exposed to aerosol-generating procedures, had a lower risk of infection compared to HCWs who declared using mainly surgical masks. On the contrary, when caring for non COVID-19 patients, wearing a respirator compared to a surgical mask was found to be a risk factor of infection. Numerous studies have described the transmission of SARS-CoV2, and masks and respirators are the key elements of PPE when caring for COVID-19 positive patients [5,15]. In other situations, the discomfort of the equipment leading to HCWs touching the respirator to adjust it, therefore contaminating their hands could explain our findings. Respirators also need to be well fitting, and a badly fitting respirator could lead to a false sense of security by not providing a sufficient level of protection [16]. Violante et al. published a systematic review of scientific literature on the protective efficacy of surgical masks and respirators against airborne viral infections [17]. Although this review was not specific to the SARS-CoV2 virus, current evidence suggests that surgical masks and respirators provide a similar level of protection, and respirators should be used selectively for greater risk situations such as aerosol-generating procedures due to the cost, discomfort and risk of badly-fitting respirators [18,19]. However, we cannot exclude that some HCWs cared for COVID-19 patients that were more critically ill, with longer hospitalizations, particularly in intensive care. In this case, the reduced risk of infection could have been due to less contagious patients, rather than to a protective effect of PPE.

When caring for non-COVID-19 patients, we found that HCWs who declared using gloves for all types of patient care had a higher risk of infection, possibly explained by improper use of PPE increasing risk of contamination. In this situation, HCWs may have considered risk of contamination to be very low. Vigilance to correct use of PPE may therefore be lowered, and risk of contamination due to misuse of PPE may increase. This has been proven for various infections, by decreasing the amount of hand hygiene HCWs perform when wearing gloves and cross contamination when HCWs do not systematically change gloves between patients [20]. Surprisingly, we found similar results for face shields and protective goggles, which HCWs however declared using very rarely in this situation. Again, improper use of these PPE or underuse of other PPE which should be associated with the face shields and goggles could be an explanation. Wearing of protective overshoes was not found to be a protective measure, in accordance with guidelines [9,10].

We found an increase in risk of infection in HCWs who reported changing their uniform in a workplace changing room. Guidelines recommend wearing an outfit dedicated to the workplace as a protective measure [10,21], however communal changing rooms could increase spread of infection due to close proximity of HCWs to each other and removal of PPE during change of clothes. Before arriving on the ward and after leaving the ward, HCWs may consider the risk of contamination to be low and protective measures may therefore seem less important than when in contact with patients. The close proximity of HCWs in changing rooms due to same arrival and leaving times likely increases risk of transmission. HCWs who declared participating in meetings were found to be less at risk of infection. Due to establishment guidelines covering meeting rooms, HCWs were likely to wear proper PPE during meetings with other colleagues, thus decreasing risk of contamination. However there was no increased risk found with breaks with other colleagues or meals at the workplace canteen, two key moments when PPE, namely masks, are not worn. As with meeting rooms, health establishments produced guidelines and rules for these communal areas, with limits on the amount of people in break rooms and staff canteens, wearing of masks whenever possible and social distancing measures.

Airing of communal areas and of patients’ or residents’ rooms was not found to be a protective factor. Guidelines [22,23] recommend frequent room ventilation when possible in order to reduce potential airborne transmission [24,25]. The lack of association found with room airing evaluated by the question: “How often do you air communal areas and patients’ or residents’ rooms?” may be due to ventilation systems in place in most health establishments, therefore reducing effects of opening windows to air rooms. The frequencies may have lacked precision, with respondents choosing between 5 categories of frequency (never, rarely, regularly but less than every other day, regularly and more than every other day and every day). Guidelines [22,23] recommend airing rooms several times a day, therefore the question may have been too imprecise to provide an informative result.

This study presents some limitations. The questionnaire was filled in retrospectively by participants, and for respondents with history of COVID-19, the questions covered a short period of time before infection. HCWs were likely to not remember exactly what measures they applied during this period, although the infection was a noticeable event and had raised questions about its origin. This recall bias is unavoidable with studies based on questionnaires. Studies with a prospective measure of exposures and PPE use would help minimize this bias, observations of practices being more reliable than declarations, but are more difficult to conduct. Another limitation is that the information on the source of infection (workplace or community acquisition) was based on participants’ declarations. Although contact tracing is performed by infection prevention teams for each case of COVID-19 in HCWs, the anonymous nature of the questionnaire did not allow us to verify the source of infection reported. Moreover, the use of an online questionnaire may have prevented certain profiles of caregivers from participating in the study. Another bias may result from an involuntary overestimation of PPE use by HCWs who declared a history of COVID-19 infection, explaining our results for PPE being a risk factor (namely respirators, face shields and protective goggles) during care of non COVID-19 positive patients. Another issue is that cases and controls who completed the questionnaire did so voluntarily. Therefore, respondents may not be fully representative of the general population of HCWs in France. Unfortunately, no estimation of the global response rate within HCWs in Normandy was able to be performed. The questionnaire was sent to health establishments’ management and then relayed to HCWs. There was no feedback as to how many HCWs had access to the questionnaire from then on. Despite these biases, the fact that our results are consistent with the data in the published literature and correspond to current recommendations allows us to believe that they are reliable.

Since the beginning of the pandemic, studies have demonstrated the higher risk of infection for HCWs, particularly exposed to the virus [11,26]. Until widespread vaccination, hand hygiene and correct use of PPE were the main barriers against the spread of COVID-19 infection [9,10,15,16,27]. Due to the emergence of new variants of the virus, with modifications of modes of transmission, infectivity, and response to vaccines, studying correct use of PPE is paramount [8]. Improper use of PPE should be highlighted as much as underuse of PPE. Because we are dealing with a moving target, further studies on risk factors and exposures are needed in order to minimize risk of infection within HCWs. Our results highlight the importance of proper use of PPE as a preventative measure against infection for HCWs.

Supporting information

S1 File

(CSV)

S2 File

(CSV)

Acknowledgments

We thank all of the participants in the study, as well as management and infection control teams who relayed the information about the study to health care workers in Normandy. All of the authors thank Josiane Lebeltel for her help in conveying the study to health establishments.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

Decision Letter 0

Ginny Moore

24 Jan 2022

PONE-D-21-34140Professional practice for COVID-19 risk reduction among health care workers : a Cross-Sectional Study with Matched Case-Control ComparisonPLOS ONE

Dear Dr. THIBON,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Unfortunately, I was only able to secure one review. However, after carefully assessing the comments and the manuscript, I agree with the assessment of the reviewer. You describe a very interesting and relevant study. Nonetheless, your manuscript does require some modification before it can be considered for publication.

Specific comments are detailed below but, as you will see, the revisions required are, in general, very minor. I look forward to receiving your revised manuscript.

Please submit your revised manuscript by Mar 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ginny Moore

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Abstract (line 35) - please delete the figures 301 (14.6%) - it looks like these have been carried over from the results section. If word count allows, it would be helpful to clarify that the participants were HCW with/without contact with patients.

Introduction (line 61) - please amend citation(s) appropriately - should this read [2, 7] or [8]? Contamination of what? Do you mean "....against infection and/or onward transmission?"

Methods (line 74) - please clarify your study design. Was a single cross-sectional study and three case-control studies carried out? There is no mention of a cross-sectional study elsewhere in the manuscript.

Methods (line 95) - apologies, I was somewhat confused by the dates. The questionnaire was available from 29 March 21 to 30 June 21 but the study period for the case control studies was Sep 20 to 31 Jan 21. So were those with a history of COVID asked to provide the date of positive test and only those who tested positive between Sep and Jan were included as a case?

Table III - should the ORa associated with face shield also be in bold?

An increased risk of infection associated with PPE use with non-COVID patients is an interesting finding. Relatively few HCWs reported using mainly respirators and regularly using gowns - were they the same participants?

Table IV - an increased risk associated with changing in the workplace is another very interesting finding. Presumably, the data included in Tables II and III are associated with only those participants who are in contact with patients. Does Table IV include all participants regardless of profession?

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

The submitted study is well conducted and provides valuable information regarding HCW PPE use, measures to prevent inter-HCW spread of infection, and associated risk of acquiring covid-19 infection. Results are retrospective and rely on an internet based survey which confers some risks. Several of these are addressed adequatly in the discussison. However, I have a few points that I find would be of interest to clarify further in the discussion.

1. It is stated that the study was conducted during months when PPE was available and prior to vaccine availability. I think this period is a wize and deliberate choice. However, you state that most cases in 2020 were from March and April, at an early time point of the pandemic, when I suspect the situation was more chaotic. Were PPE supplies already sufficient by then so that recommended Infection control practices could be adhered to?

2. Even though a majority of covid-19 positive participants reported the possible source of infection was their work place, and most often infected patients, the uncertainty of such an assumption, specifically during wide spread dissemination in the community, should be discussed. Working with covid-19 patients will probably raise the suspicion of of them being the source, which is not necessarily true

3. Using respirators all the time or only when performing AGPs correlated with a reduced risk of infection. A reason could be better protection against contagious aerosols. An alternative protection could be that HCWs in these situations cared for patients that were more critically ill, at later time points of disease when viable virus less often can be recovered and the risk of infection therefore is significantly reduced. Working in intensive care with covid-19 patients has been associated with a reduced risk in previous reports.

The same may be true for the reduced risk associated with hair caps which may have been more commonly used by HCWs caring for critically ill patients (who are less contagious). Is this so, otherwize how can the reduced risk associated with hair cap use be reliably explained?

4. The study was performed prior to the alpha VOC, and I believe that the statement that covid-19 mainly spread via respiratory droplets in close proximity to an infectious person was true. Since then ever more infectious various variants have emerged from alpha via delta, and now omicron VOC. It needs to be discussed if the abundance of more infectious variants perhaps necessitates altered infection control measures, including PPE use, such as respirator use during care of covid-19 patients regardless of AGP. Perhaps also hint to an uncertainty as to whether the results of the same study, if performed today, would generate the same results. We are dealing with a moving target and infection control practices that were adequate yesterday may not be so today.

Kind regards

Ulf Karlsson, MD, PhD

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ulf Karlsson, MD

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 21;17(3):e0264232. doi: 10.1371/journal.pone.0264232.r002

Author response to Decision Letter 0


1 Feb 2022

Professional practice for COVID-19 risk reduction among health care workers: a Cross-Sectional Study with Matched Case-Control Comparison

PONE-D-21-34140

>Thank you very much for considering our work. Please find below our responses to the comments of the academic editor and of the reviewer.

Editor:

1/ Abstract (line 35) - please delete the figures 301 (14.6%) - it looks like these have been carried over from the results section. If word count allows, it would be helpful to clarify that the participants were HCW with/without contact with patients.

>Agreed and done – The word count of the abstract is now 238.

2/ Introduction (line 61) - please amend citation(s) appropriately - should this read [2, 7] or [8]? Contamination of what? Do you mean "....against infection and/or onward transmission?"

>The right citation was [8]. We meant “onward transmission” and clarified this point in the sentence.

3/ Methods (line 74) - please clarify your study design. Was a single cross-sectional study and three case-control studies carried out? There is no mention of a cross-sectional study elsewhere in the manuscript.

>Thanks for this comment: we also think that our methodology needs to be clarified. In the questionnaire, we asked participants about their history of COVID-19 infection, vaccination status, and PPE applied at work. This is the “cross sectional” part of the study. We also collected in the questionnaire retrospective information on PPE use in case of history of COVID-19, which allowed us to carry out the case-control studies.

The mention “cross sectional study with matched case-control comparison” appeared in the title and in the “Material and method” part of the first version of the manuscript. We added mention to the “cross sectional” design in the section of the new manuscript presenting the results of this part of the study (line 145).

4/ Methods (line 95) - apologies, I was somewhat confused by the dates. The questionnaire was available from 29 March 21 to 30 June 21 but the study period for the case control studies was Sep 20 to 31 Jan 21. So were those with a history of COVID asked to provide the date of positive test and only those who tested positive between Sep and Jan were included as a case?

>Exactly! A total of 301 HCW declared a history of COVID-19. Of these 301, 109 had the infection during the case-control study period (sept 20->jan 21). We added “… history of COVID-19 infection with date of infection (confirmed by a positive SARS-CoV2 PCR or antigenic test” in the part “Period and Data acquisition” of the “Methods” section.

5/ Table III - should the ORa associated with face shield also be in bold?

>Agreed and done

6/ An increased risk of infection associated with PPE use with non-COVID patients is an interesting finding. Relatively few HCWs reported using mainly respirators and regularly using gowns - were they the same participants?

>They were not the same participants: of the 5 HCW declaring using mainly respirators, 3 declared using gowns regularly and 2 rarely.

7/ Table IV - an increased risk associated with changing in the workplace is another very interesting finding. Presumably, the data included in Tables II and III are associated with only those participants who are in contact with patients. Does Table IV include all participants regardless of profession?

>Table IV includes all participants, regardless of profession, with/without contact with patients. To clarify this point, we added “all professions included” in the title of table IV.

Reviewer #1:

The submitted study is well conducted and provides valuable information regarding HCW PPE use, measures to prevent inter-HCW spread of infection, and associated risk of acquiring covid-19 infection. Results are retrospective and rely on an internet based survey which confers some risks. Several of these are addressed adequatly in the discussison. However, I have a few points that I find would be of interest to clarify further in the discussion.

>Thank you very much for your comment. Please find our answers below. We agree with the limitations of the study related to the retrospective design and mode of data acquisition.

1. It is stated that the study was conducted during months when PPE was available and prior to vaccine availability. I think this period is a wize and deliberate choice. However, you state that most cases in 2020 were from March and April, at an early time point of the pandemic, when I suspect the situation was more chaotic. Were PPE supplies already sufficient by then so that recommended Infection control practices could be adhered to?

>The choice of the period for the case-control studies was indeed deliberate. At the early point of the pandemic, PPE supplies were not sufficient, and recommendations were still evolving. In response to a comment from the academic editor and to your comment, we clarified the fact that the cases included in the case-control studies were only those that occurred between September 2020 and January 2022, during a period when PPE was more readily available. Cases were asked to report their practice in the days before their infection.

2. Even though a majority of covid-19 positive participants reported the possible source of infection was their work place, and most often infected patients, the uncertainty of such an assumption, specifically during wide spread dissemination in the community, should be discussed. Working with covid-19 patients will probably raise the suspicion of of them being the source, which is not necessarily true

>In France (as in other countries most likely), cases of COVID-19 in healthcare workers are reported to infection control teams and contact tracing is performed. A search for sources of infection (community, other HCW, patient) is made, as well a screening tests among contacts. But we agree with you that the information on the source of infection was only based on declarations of participants. Since participation in the study was anonymous, it was impossible to verify the information.

We added this sentence in the Discussion part: “Another limitation is that the information on the source of infection (workplace or community acquisition) was based on participants’ declarations. Although contact tracing is performed by infection prevention teams for each case of COVID-19 in HCW, the anonymous nature of the questionnaire did not allow us to verify the source of infection reported.”

3. Using respirators all the time or only when performing AGPs correlated with a reduced risk of infection. A reason could be better protection against contagious aerosols. An alternative protection could be that HCWs in these situations cared for patients that were more critically ill, at later time points of disease when viable virus less often can be recovered and the risk of infection therefore is significantly reduced. Working in intensive care with covid-19 patients has been associated with a reduced risk in previous reports.

The same may be true for the reduced risk associated with hair caps which may have been more commonly used by HCWs caring for critically ill patients (who are less contagious). Is this so, otherwize how can the reduced risk associated with hair cap use be reliably explained?

>Thank you for this comment. We agree that the length of stay of patients could be a confounding factor in the link between the use of certain PPE and the reduction of risk: the reduction of risk being linked to less infectious patients rather than to the use of PPE. We did not address this point, which could be a convincing explanation for some of our findings (regarding hair caps especially).

We added this paragraph in the discussion: “However, we cannot exclude that some HCW cared for COVID-19 patients that were more critically ill, with longer hospitalizations, particularly in intensive care. In this case, the reduced risk of infection could have been due to less contagious patients, rather than to a protective effect of PPE.”

4. The study was performed prior to the alpha VOC, and I believe that the statement that covid-19 mainly spread via respiratory droplets in close proximity to an infectious person was true. Since then ever more infectious various variants have emerged from alpha via delta, and now omicron VOC. It needs to be discussed if the abundance of more infectious variants perhaps necessitates altered infection control measures, including PPE use, such as respirator use during care of covid-19 patients regardless of AGP. Perhaps also hint to an uncertainty as to whether the results of the same study, if performed today, would generate the same results. We are dealing with a moving target and infection control practices that were adequate yesterday may not be so today.

>We totally agree with your comment, particularly in the current context of the diffusion of the omicron VOC. We modified our conclusion, and with your permission, we would like to use the term ”moving target”, which seems perfectly appropriate to us: “Due to the emergence of new variants of the virus, with modifications of modes of transmission, infectivity and response to vaccines, studying correct use of PPE is paramount [8]. Improper use of PPE should be highlighted as much as underuse of PPE. Because we are dealing with a moving target, further studies on risk factors and exposures are needed in order to minimize risk of infection within HCWs”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Ginny Moore

7 Feb 2022

Professional practice for COVID-19 risk reduction among health care workers : a Cross-Sectional Study with Matched Case-Control Comparison

PONE-D-21-34140R1

Dear Dr. THIBON,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ginny Moore

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ulf Karlsson, MD, PhD, Dep of Infectious diseases and Infection Control, Skane University Hospital, Sweden

Acceptance letter

Ginny Moore

10 Mar 2022

PONE-D-21-34140R1

Professional practice for COVID-19 risk reduction among health care workers: a Cross-Sectional Study with Matched Case-Control Comparison

Dear Dr. Thibon:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ginny Moore

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (CSV)

    S2 File

    (CSV)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES